1. Home
  2. CINGW vs MGEE Comparison

CINGW vs MGEE Comparison

Compare CINGW & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • MGEE
  • Stock Information
  • Founded
  • CINGW N/A
  • MGEE 1855
  • Country
  • CINGW United States
  • MGEE United States
  • Employees
  • CINGW 13
  • MGEE N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • MGEE Electric Utilities: Central
  • Sector
  • CINGW Health Care
  • MGEE Energy
  • Exchange
  • CINGW Nasdaq
  • MGEE Nasdaq
  • Market Cap
  • CINGW N/A
  • MGEE 3.8B
  • IPO Year
  • CINGW 2021
  • MGEE N/A
  • Fundamental
  • Price
  • CINGW $0.04
  • MGEE $94.46
  • Analyst Decision
  • CINGW
  • MGEE Sell
  • Analyst Count
  • CINGW 0
  • MGEE 1
  • Target Price
  • CINGW N/A
  • MGEE $74.00
  • AVG Volume (30 Days)
  • CINGW N/A
  • MGEE 188.9K
  • Earning Date
  • CINGW N/A
  • MGEE 02-19-2025
  • Dividend Yield
  • CINGW N/A
  • MGEE 1.91%
  • EPS Growth
  • CINGW N/A
  • MGEE N/A
  • EPS
  • CINGW N/A
  • MGEE 3.27
  • Revenue
  • CINGW N/A
  • MGEE $653,681,000.00
  • Revenue This Year
  • CINGW N/A
  • MGEE $2.14
  • Revenue Next Year
  • CINGW N/A
  • MGEE $4.75
  • P/E Ratio
  • CINGW N/A
  • MGEE $28.79
  • Revenue Growth
  • CINGW N/A
  • MGEE N/A
  • 52 Week Low
  • CINGW N/A
  • MGEE $61.94
  • 52 Week High
  • CINGW N/A
  • MGEE $109.22
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • MGEE 36.58
  • Support Level
  • CINGW N/A
  • MGEE $91.94
  • Resistance Level
  • CINGW N/A
  • MGEE $96.45
  • Average True Range (ATR)
  • CINGW 0.00
  • MGEE 2.70
  • MACD
  • CINGW 0.00
  • MGEE -1.17
  • Stochastic Oscillator
  • CINGW 0.00
  • MGEE 18.17

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About MGEE MGE Energy Inc

MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings. MGE's generation mix is 40% coal, 21% renewable energy, 17% natural gas, and third-party purchased power.

Share on Social Networks: